Shopping Cart
- Remove All
Your shopping cart is currently empty
Enavogliflozin (DWP-16001) is an orally available small molecule and sodium glucose transporter 2 inhibitor.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $158 | In Stock | |
| 5 mg | $397 | In Stock | |
| 10 mg | $622 | In Stock | |
| 25 mg | $1,080 | In Stock | |
| 50 mg | $1,480 | In Stock | |
| 100 mg | $1,960 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $437 | In Stock |
| Description | Enavogliflozin (DWP-16001) is an orally available small molecule and sodium glucose transporter 2 inhibitor. |
| Targets&IC50 | ERG (human):44.9 µM, SGLT2:0.8 ± 0.3 nM, SGLT2 (human):0.43 nM |
| In vitro | Enavogliflozin (DWP-16001), a best-in-class antidiabetic agent, functions as a selective and orally active sodium-glucose cotransporter-2 (SGLT-2) inhibitor, as supported by references [1][2][3]. |
| Synonyms | DWP-16001 |
| Molecular Weight | 446.92 |
| Formula | C24H27ClO6 |
| Cas No. | 1415472-28-4 |
| Smiles | OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1cc(Cc2ccc(cc2)C2CC2)c(Cl)c2OCCc12 |
| Relative Density. | 1.438 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (223.75 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.